Cargando…
Bioengineering of Virus-like Particles for the Prevention or Treatment of Allergic Diseases
Recent findings on the mechanism of allergen-specific immunotherapy (AIT) have revisited the role of immunoglobulin G (IgG) as the development of specific blocking IgG antibodies appeared critical for the successful suppression of T-helper 2 (Th2)-biased allergic responses. Consequently, any form of...
Autores principales: | Pechsrichuang, Phornsiri, Namwongnao, Supannika, Jacquet, Alain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680827/ https://www.ncbi.nlm.nih.gov/pubmed/33191675 http://dx.doi.org/10.4168/aair.2021.13.1.23 |
Ejemplares similares
-
Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases
por: Klimek, Ludger, et al.
Publicado: (2018) -
OmpA signal peptide leads to heterogenous secretion of B. subtilis chitosanase enzyme from E. coli expression system
por: Pechsrichuang, Phornsiri, et al.
Publicado: (2016) -
Efficient oral vaccination by bioengineering virus-like particles with protozoan surface proteins
por: Serradell, Marianela C., et al.
Publicado: (2019) -
Secretory production of a beta-mannanase and a chitosanase using a Lactobacillus plantarum expression system
por: Sak-Ubol, Suttipong, et al.
Publicado: (2016) -
Virus-like Particles as Preventive and Therapeutic Cancer Vaccines
por: Tornesello, Anna Lucia, et al.
Publicado: (2022)